...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Here is the example of the danger of the COVID trial to RVX...

KillerNut

According to clinical trials.gov, recruiting began 8/13/21 for the IPIX trial which had 120 patients - I am assuming that the last update to the trial site was the date recruiting began ~ 90 days from recruiting start until data lock last week and results yesterday -  all things being equal - that  puts Rvx results announcement ~ 1/31/22 - maybe sooner with 17% less patients

i was in IPIX but fortunately unloaded before they began this trial - not so with RVXCF - still all in - I believe Apabetalone meets endpoints - as I recall, IPIX was trading around .10 to .15 before the COVID trial start announcement then spiked upward in speculation - now back down to .08. RVX has not had the same trajectory - no spike on trial announcement - possibly because they too recently failed to meet Betonmace targeted outcomes and not well covered or known in US - primary market is TSX

risky business

Chicagoest

 

Share
New Message
Please login to post a reply